Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106687 (US8586571, 50) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106685 (US8586571, 17) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106694 (US8586571, 207) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106691 (US8586571, 164) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106688 (US8586571, 80) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106681 (US8586571, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106690 (US8586571, 143) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106684 (US8586571, 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106695 (US8586571, 215) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106682 (US8586571, 36) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106693 (US8586571, 197) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106692 (US8586571, 189) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106683 (US8586571, 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106686 (US8586571, 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Retinol-binding protein 4 (Homo sapiens (Human)) | BDBM106689 (US8586571, 121) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 790 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu... | US Patent US8586571 (2013) BindingDB Entry DOI: 10.7270/Q26W98QK | |||||||||||
More data for this Ligand-Target Pair |